clinical trial · NCT06316973
A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants
Clear Scientific, Inc.·phase1·completed·n = 32
Substance Use DisordersMethamphetamine AbuseMethamphetamine IntoxicationCS-1103Sterile Saline
brief summary
The purpose of this Phase 1a study is to evaluate safety, tolerability, and pharmacokinetics (PK) of single, ascending doses of CS-1103, administered by intravenous (IV) infusion in healthy participants.
started
Feb 7, 2024
primary completion
May 30, 2024
completion
Jun 6, 2024
last updated
Nov 10, 2025
official title
A Phase 1a, Randomized, Double-Blind, Placebo-Controlled, Single Center Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CS-1103 Following Single, Ascending Intravenous Dose Administration in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol